News FDA and EMA to work more closely on paediatric drug regulati... FDA and EMA hope to streamline development of paediatric plans.
News EU data rules to impact pharma interaction with doctors Data protection regs will require better data management.
News Pfizer looks to confirm US licence for breast cancer pill Pfizer has filed late stage data with FDA.
News EU approval for Crohn's another boost for fast-growing Stela... J&J unit's blockbuster gets new use.
News PTC's muscular dystrophy drug can stay on EU market - regula... But PTC must conduct further trial to confirm Translarna's benefits.
News Biogen/Ionis could launch rare disease drug within weeks Companies prepare for launch of Spinraza after phase 3 success.
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
